The installation of Kiestra Total Laboratory Automation (TLA) systems, which is expected by the third quarter of 2013, will enable CML to increase its capacity, reduce result turnaround times, and contribute to the growth of the core laboratory business.
CML HealthCare president and CEO Thomas Wellner said, "With our central laboratory processing approximately three million microbiology tests annually, this installation will be the largest in the world for the BD Kiestra TLA system."
The system, which automates the manual processes associated with inoculating and incubating microbiology specimens, uses digital imaging of the inoculated specimens to shorten the time to detect bacterial growth.
BD Diagnostics diagnostic systems president Tom Polen said, "We expect this to enable clinicians to provide patients with the most effective treatment earlier – thus improving the standard of care and avoiding unnecessary healthcare costs."
